Improving the Timely Detection of Bladder and Kidney Cancer in Primary Care

Overview

Journal Adv Ther

Date 2019 May 19

PMID 31102201

Citations 8

Authors

Yin Zhou

Garth Funston

Georgios Lyratzopoulos

Fiona M Walter

Affiliations

Soon will be listed here.

Abstract

Bladder and kidney cancer are the 10th and 7th most common cancers in the United Kingdom (UK). They present with symptoms that are typically investigated via the same diagnostic pathway. However, diagnosing these cancers can be challenging, especially for kidney cancer, as many of the symptoms are non-specific and occur commonly in patients without cancer. Furthermore, the recognition and evaluation of these symptoms may differ because of the lack of supporting high-quality evidence to inform management, a problem also reflected in currently ambiguous guidelines. The majority of these two cancers are diagnosed following a referral from a general practitioner. In this article, we summarise current UK and United States (US) guidelines for investigating common symptoms of bladder and kidney cancer-visible haematuria, non-visible haematuria and urinary tract infections. Our article aims to support clinicians in recognising and investigating patients with symptoms of possible bladder and kidney cancer in a timely fashion. We discuss challenges during the diagnostic process and possible future interventions for improvement.

Citing Articles

The sex gap in bladder cancer survival - a missing link in bladder cancer care?.

Toren P, Wilkins A, Patel K, Burley A, Gris T, Kockelbergh R Nat Rev Urol. 2023; 21(3):181-192.

PMID: 37604983 DOI: 10.1038/s41585-023-00806-2.

Symptoms and signs of urogenital cancer in primary care.

Holtedahl K, Borgquist L, Donker G, Buntinx F, Weller D, Campbell C BMC Prim Care. 2023; 24(1):107.

PMID: 37101110 PMC: 10131418. DOI: 10.1186/s12875-023-02063-z.

Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.

Papavasiliou E, Sills V, Calanzani N, Harrison H, Snudden C, di Martino E Cancers (Basel). 2023; 15(3).

PMID: 36765672 PMC: 9913596. DOI: 10.3390/cancers15030709.

Routine urethroscopic surveillance is of limited value after radical cystectomy: a single centre retrospective cohort analysis.

Devlin C, Molokwu C, Wood B, Yuen K, Singh R, Chahal R Int Urol Nephrol. 2022; 54(12):3139-3144.

PMID: 35951254 DOI: 10.1007/s11255-022-03312-3.

Identifying opportunities for timely diagnosis of bladder and renal cancer via abnormal blood tests: a longitudinal linked data study.

Zhou Y, Walter F, Mounce L, Abel G, Singh H, Hamilton W Br J Gen Pract. 2021; 72(714):e19-e25.

PMID: 34903517 PMC: 8714503. DOI: 10.3399/BJGP.2021.0282.

References

Akhtar S, Al-Shammari A, Al-Abkal J . Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies. World J Urol. 2018; 36(6):839-848. DOI: 10.1007/s00345-018-2206-x. View

Price S, Shephard E, Stapley S, Barraclough K, Hamilton W . Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care. Br J Gen Pract. 2014; 64(626):e584-9. PMC: 4141616. DOI: 10.3399/bjgp14X681409. View

Shephard E, Neal R, Rose P, Walter F, Hamilton W . Clinical features of kidney cancer in primary care: a case-control study using primary care records. Br J Gen Pract. 2013; 63(609):e250-5. PMC: 3609472. DOI: 10.3399/bjgp13X665215. View

Loo R, Lieberman S, Slezak J, Landa H, Mariani A, Nicolaisen G . Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013; 88(2):129-38. DOI: 10.1016/j.mayocp.2012.10.004. View

Neal R, Tharmanathan P, France B, Din N, Cotton S, Fallon-Ferguson J . Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015; 112 Suppl 1:S92-107. PMC: 4385982. DOI: 10.1038/bjc.2015.48. View

Lyratzopoulos G, Neal R, Barbiere J, Rubin G, Abel G . Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012; 13(4):353-65. DOI: 10.1016/S1470-2045(12)70041-4. View

Elmussareh M, Young M, Sundelin M, Bak-Ipsen C, Graumann O, Jensen J . Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark. Scand J Urol. 2017; 51(4):282-289. DOI: 10.1080/21681805.2017.1310759. View

Koo M, Hamilton W, Walter F, Rubin G, Lyratzopoulos G . Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence. Neoplasia. 2017; 20(2):165-174. PMC: 5735300. DOI: 10.1016/j.neo.2017.11.005. View

Shephard E, Stapley S, Neal R, Rose P, Walter F, Hamilton W . Clinical features of bladder cancer in primary care. Br J Gen Pract. 2012; 62(602):e598-604. PMC: 3426598. DOI: 10.3399/bjgp12X654560. View

10.

Cohn J, Vekhter B, Lyttle C, Steinberg G, Large M . Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer. 2014; 120(4):555-61. PMC: 3916781. DOI: 10.1002/cncr.28416. View

11.

Linder B, Bass E, Mostafid H, Boorjian S . Guideline of guidelines: asymptomatic microscopic haematuria. BJU Int. 2017; 121(2):176-183. DOI: 10.1111/bju.14016. View

12.

Zhou Y, Abel G, Hamilton W, Pritchard-Jones K, Gross C, Walter F . Diagnosis of cancer as an emergency: a critical review of current evidence. Nat Rev Clin Oncol. 2016; 14(1):45-56. DOI: 10.1038/nrclinonc.2016.155. View

13.

Smittenaar C, Petersen K, Stewart K, Moitt N . Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016; 115(9):1147-1155. PMC: 5117795. DOI: 10.1038/bjc.2016.304. View

14.

Hamilton W, Green T, Martins T, Elliott K, Rubin G, Macleod U . Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract. 2013; 63(606):e30-6. PMC: 3529290. DOI: 10.3399/bjgp13X660751. View

15.

Hollenbeck B, Dunn R, Ye Z, Hollingsworth J, Skolarus T, Kim S . Delays in diagnosis and bladder cancer mortality. Cancer. 2010; 116(22):5235-42. DOI: 10.1002/cncr.25310. View

16.

Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A . Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study. Urol Int. 2014; 94(1):37-44. DOI: 10.1159/000363334. View

17.

Lyratzopoulos G, Abel G, McPhail S, Neal R, Rubin G . Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open. 2013; 3(6). PMC: 3693425. DOI: 10.1136/bmjopen-2013-002861. View

18.

Richards K, Ham S, Cohn J, Steinberg G . Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities. Int J Urol. 2015; 23(1):42-7. DOI: 10.1111/iju.12959. View

19.

Bassett J, Alvarez J, Koyama T, Resnick M, You C, Ni S . Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries. J Gen Intern Med. 2014; 30(4):440-7. PMC: 4371014. DOI: 10.1007/s11606-014-3116-2. View

20.

Yeung C . Scottish referral guidelines for suspected cancer. Br Dent J. 2019; 226(7):472-473. DOI: 10.1038/s41415-019-0214-x. View